Correlation Between Abcellera Biologics and HF Sinclair

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and HF Sinclair at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and HF Sinclair into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and HF Sinclair Corp, you can compare the effects of market volatilities on Abcellera Biologics and HF Sinclair and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of HF Sinclair. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and HF Sinclair.

Diversification Opportunities for Abcellera Biologics and HF Sinclair

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Abcellera and DINO is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and HF Sinclair Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HF Sinclair Corp and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with HF Sinclair. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HF Sinclair Corp has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and HF Sinclair go up and down completely randomly.

Pair Corralation between Abcellera Biologics and HF Sinclair

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 1.81 times more return on investment than HF Sinclair. However, Abcellera Biologics is 1.81 times more volatile than HF Sinclair Corp. It trades about 0.1 of its potential returns per unit of risk. HF Sinclair Corp is currently generating about -0.18 per unit of risk. If you would invest  244.00  in Abcellera Biologics on September 25, 2024 and sell it today you would earn a total of  51.00  from holding Abcellera Biologics or generate 20.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Abcellera Biologics  vs.  HF Sinclair Corp

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
HF Sinclair Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HF Sinclair Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Abcellera Biologics and HF Sinclair Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and HF Sinclair

The main advantage of trading using opposite Abcellera Biologics and HF Sinclair positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, HF Sinclair can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HF Sinclair will offset losses from the drop in HF Sinclair's long position.
The idea behind Abcellera Biologics and HF Sinclair Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bonds Directory
Find actively traded corporate debentures issued by US companies